23 July 2024 : Original article
Engraftment Syndrome in Autologous Hematopoietic Stem Cell Transplant Patients: Incidence, Associated Risk Factors, Features, and Outcomes
Sira Mongkolrat1ABCDEF, Adisak Tantiworawit
2ADE*, Piangrawee Niprapan 2E, Pokpong Piriyakhuntorn 3BDE, Teerachat Punnachet 2E, Nonthakorn Hantrakun 2E, Thanawat Rattanathammethee 2E, Sasinee Hantrakool 2E, Chatree Chai-Adisaksopha 2E, Ekarat Rattarittamrong 2E, Lalita Norasetthada 2E
DOI: 10.12659/AOT.944043
Ann Transplant 2024; 29:e944043
Table 4 Outcome of transplantation.
| Overall | ES | Non-ES | P value | |
|---|---|---|---|---|
| Length of stay (day) (SD) | 18.9 (±7.6) | 22.5 (±8.2) | 16.9 (±6.4) | <0.001 |
| NRM (%) | 4 (3.2) | 1 (2.2) | 3 (3.8) | 1.000 |
| TRM (%) | 2 (1.6) | 0 (0) | 2 (2.5) | 0.534 |
| Graft failure (%) | 3 (2.4) | 2 (4.4) | 1 (1.3) | 0.298 |
| t-MDS (%) | 1 (0.81) | 0 (0) | 1 (1.27) | 1.000 |
| Secondary malignancy (%) | 1 (0.81) | 0 (0) | 1 (1.27) | 1.000 |
| Antibiotic duration (day) (IQR) | 12 (9–16) | 16 (11–20) | 11 (8–14) | <0.001 |
| Antifungal duration (day) (IQR) | 7 (4.5–14) | 5 (4–12) | 9 (7–14.5) | 0.233 |
| Amphotericin B use (%) | 28 (22.6) | 17 (37.8) | 11 (13.9) | 0.003 |
| Packed red cell, U (IQR) | 0.5 (0–1) | 1 (0–2) | 0 (0–1) | 0.123 |
| Platelet, U (IQR) | 15 (10–24) | 15 (10–30) | 15 (10–23) | 0.156 |
| Corticosteroid use (%) | 12 (9.7) | 12 (26.7) | 0 (0) | <0.001 |
| NRM – non-relapse mortality; TRM – transplantation-related mortality; t-MDS – transplantation-related myelodysplastic syndrome. | ||||